With the Covid-19 pandemic impacting societies and economies worldwide, the effects of innovation in pharma as it aims to overcome the disruption to supply chains and operations is having a dramatic impact on the health and wellness of millions of people. For Jay Galeota, President and Chief Executive Officer of Inheris BioPharma Inc., innovation is a central element to incorporate into the mission of any organization.

?Innovation is typically viewed as this ?light bulb? moment, but in my mind innovation should be happening at all levels of an organization all the time,? says Galeota. ?If companies can create cultures where there is an expectation for people to innovate, and there is an incentive and desire to innovate, this will then become inherent in the environment people are in and it can also be delivered to the market. To me, this is what is behind creating an innovation culture and what innovation should be defined as.?

In this interview, we look at how innovation processes can be configured to create and manage new ideas in the supply chain. Galeota also touches on the importance of stepping out of your comfort zone to push innovation processes forward.